drugset / Trial / NCT05074420
A Study of Baricitinib (LY3009104) in Children With COVID-19
NaSingle-groupOpen-labelTreatment
Summary
The purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose.
Timeline
- Start
- 2021-12-21
- Primary completion
- 2024-09-05
- Completion
- 2024-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | — | Oral |